Blog
882 Articles
A New Immunotherapy Drug to Make Chemotherapy More Effective for Metastatic Pancreatic Cancer
Researchers are testing a new immunotherapy drug to make standard chemotherapy more effective for metastatic pancreatic cancer.
ASCO GI Symposium Features a Broad Range of Pancreatic Cancer Research
Researchers at ASCO GI 2024 reported on research in health disparities, KRAS and other genetic mutations, and novel treatments.
Don’t Give Up
Joe Pearson responded so well to chemotherapy that even with a stage III tumor near a blood vessel he was able to have Whipple surgery.
Steely Strength to Keep Going
Long-term survivor Davi D’Agostino discovered she carries the BRCA2 mutation, which changed her treatment plan to targeted therapy.
Comprehensive Molecular Test Helps Classify Pancreatic Cysts
Dr. Aatur Singhi and colleagues are developing a test to help determine whether pancreatic cysts are likely to turn cancerous.
Always Insist On More
Dave Paffenroth’s wife Wendy was an extraordinary caregiver, coordinating treatments and family support during pancreatic cancer treatment.
Treating High Blood Sugar in People With Pancreatic Cancer
A new clinical trial explores the effectiveness of the drug glipizide in controlling high blood sugar in pancreatic cancer patients.
Progress and Promise—Research in 2023
What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?
A Long Journey That Began With Pancreatitis
Paul Suntup’s diagnosis of acinar cell pancreatic cancer was just the start of a long treatment journey, but he’s still here.
Navigating Cold and Flu Season as a Cancer Patient
Are you in treatment and planning to see friends or family for the holidays? Learn the best ways to protect yourself from cold, flu, and other viruses.
Let’s Win Pancreatic Cancer Survivors Series—Year Seven
Our Survivors Video Series is entering Year Seven with even more inspiring stories of taking on pancreatic cancer and life.
Targeted Protein Degradation to Treat Advanced Solid Tumors
A clinical trial tests the effectiveness of a molecule that causes protein degradation in tumor cells, including pancreatic cancer cells.
Understanding How Super-Enhancers Rev Up Pancreatic Cancer Growth
Researcher Ronald Evans, Ph.D., and his team at the Salk Institute are focusing on how super-enhancers stimulate pancreatic cancer growth.
Being Aggressive Paid Off
Lynn Perkins was only 42 when she was diagnosed with stage I pancreatic cancer, so she wanted aggressive treatment. That was in 2004!
CRISPR: A New Tool to Help Understand Cancer-Linked Mutations
Lukas Dow, Ph.D., is using CRISPR technology to find better ways to fight cancer by editing the genome.